Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Options flow this week split sharply. Calls are piling into industrials and transport. Puts are landing on last year's darlings.
Union Pacific, CSX and Parker-Hannifin each showed 100% bullish options flow over the past week, per ORTEX data. That is every tracked options order skewing toward calls. Union Pacific carries an unusual 13 days-to-cover, yet sentiment is still call-heavy.
The backdrop matters. Japan's foreign machine tool orders jumped 66% year-on-year in August to JPY 146,350m, according to ORTEX Alt Data. Machine tool demand is a read on global capital spending. For rail and industrial equipment names, that is a supporting signal heading into Q3 earnings season.
Parker-Hannifin is up 12% year-to-date. has gained 31%. Analysts see an average 18% further upside in Union Pacific.
The sharpest bearish options flow sits on stocks that have lost heavily in 2026. AppLovin is down 59% year-to-date. Its options score hit the lowest tier in ORTEX's US universe. Negative bets dominated. CrowdStrike is off 40% and drew the largest bearish options dollar flow among high-score negative names.
MGM Resorts stands out with an RSI of just 15. That is deeply oversold territory. Yet options flow remains negative-heavy. Lululemon is down 55% year-to-date and sits among the most put-skewed large caps in the consumer sector.
Marvell Technology is up 238% year-to-date after analysts cited a $400bn AI opportunity. Shares fell anyway. Delta Air Lines faces its Q3 earnings call imminently. It is one of the few large-caps where bearish options activity is elevated despite a 21% analyst upside consensus.
Europe's petrol car registrations fell to a record September low of 5,821 vehicles, per ORTEX Alt Data. That adds pressure on auto-adjacent names. Diesel registrations have now fallen for three straight months.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
